Monte - Bred for racing. Meant for more. A Cytowave OTTB success story

Monte suffered a severe 40% tear of his tendon. After 12 weeks of Cytowave treatments, the lesion closed and he was ready to begin rehabilitation. To the left is Monte, back in competition. Below, Monte with his mom. To read the case studies, go to Case Studies:

---

With the Breeder’s Cup Championships right around the corner, the buzz from track to tack room is who will enter into the Hall of Champions. Since 1984, the Breeder’s Cup has produced champions that will be eternally written into the history books of these prestigious races. After October 31st, these victors will move on to lives of leisurely retirement, stud or broodmare roles, or will continue to challenge more contenders at the tracks in 2016.

However, not every racehorse is destined for this glory. Many are ruled out early on for a slew of reasons, one being an injury. A breakdown at the track is heartbreaking and can have devastating effects on the horse’s usability in the future, both on and off the track. These unfortunate souls are who Cytowave coined its’ research from. Instead of becoming pasture puffs or suffering from a far darker fate, we offer a second chance for the injured Thoroughbred; a chance where a second career becomes a possibility. 

Three Part Monty did not have a promising start to his career. A 2010 gelding with War Admiral blood-lines, he lost all of his first three races. Uninterested and unfocused, the gelding’s racing career ended abruptly but not because of the lack of enthusiasm or purse money. During training, the gelding tore 40% of his tendon, leaving his career at the track behind and his future bleak with uncertainty. Cytowave however, stepped in.

"This was the worst tendon lesion complex I had ever seen," stated Richard Parker, inventor of Cytowave.  And yet, in spite of the severity of the tear, it healed quickly. You can see the other scans here: Monte's Success Story

After only 12 weeks of treatment, the lesion healed leaving the question of “what next for Monty?”

Monty became one of Cytowave’s own first adopted race horses. Owned and trained by Cytowave member Alicia Szostak, Monty had a chance at an eventing career, which he excels at. This impassive gelding might not have had this opportunity without the effectiveness of Cytowave treating tendon lesions. 

So the next time a big race comes around and the thundering of the hooves across the finish lines resonates in your ears and leaves you breathless, remember to give OTTBs like Monty a chance; the same chance you should give Cytowave.

Monte - back in action!